Averin Capital Acquisition Corp.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Averin Capital Acquisition Corp.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
ACAA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002096900

Board of directors

Follow this board

Board connections

3 of this board's directors also sit on 5 other boards.

Network of Averin Capital Acquisition Corp.'s board connections Absci Corporation Absci Corporation Halozyme Therapeutics Inc. Halozyme Therapeutics... Kura Oncology Inc. Kura Oncology Inc. Oaktree Acquisition Corp. III Life Sciences Oaktree Acquisition Co... TriSalus Life Sciences Inc. TriSalus Life Sciences... Akiko Moni Miyashita Akiko Moni Miyashita David A. Berry David A. Berry Mary T. Szela Mary T. Szela Averin Capital Acquisition...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Feb 20, 2025 Averin Capital Acquisition Sponsor LLC Director, Officer (See Remarks), 10% owner Open-market purchase +200,000 $10.00 $2,000,000
Feb 20, 2025 Averin Capital Acquisition Sponsor LLC Director, Officer (See Remarks), 10% owner Open-market purchase +200,000 $10.00 $2,000,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.